US Patent Issued on Aug. 25 for "Cell membrane lipid-extracted nanoparticles (CLENs) for selective targeting, image analysis and cancer therapy" (Massachusetts Inventor)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,671, issued on Aug. 25.

"Cell membrane lipid-extracted nanoparticles (CLENs) for selective targeting, image analysis and cancer therapy" was invented by Robert B. Campbell (Uxbridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Nanoliposome compositions and methods of making the same for selective targeting, image analysis and therapy (e.g., cancer therapy) are provided. In some aspects, the nanoliposomes comprise membrane material derived from cells (e.g., tumor cells) in order to selectively target agents (e.g., chemotherapeutic agents) to cancer cells. Membranes used to generate the nanoliposomes provided herein may be derived from cells ...